| Financial Year |
March 31 2023 |
| Monetary Funds |
677,530,045.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
203,656,116.49 |
| Accounts Receivable |
1,919,884,899.84 |
| Advances to Suppliers |
37,344,397.00 |
| Other Receivables |
18,250,168.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
592,815,654.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,506,887.13 |
| Total Current Assets |
3,487,532,931.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
403,190,798.74 |
| Under-construction Projects |
63,107,926.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,951,001.14 |
| R&D expenses |
-- |
| Goodwill |
194,274,636.92 |
| Long-Term Deferred and Prepaid Expenses |
20,606,311.80 |
| Deferred Income Tax Assets |
50,730,083.08 |
| Other Non-Current Assets |
71,057,604.29 |
| Sub-Total of Non-Current Assets |
923,546,099.95 |
| Total Assets |
4,411,079,031.35 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
77,283,182.10 |
| Accounts Payable |
344,527,005.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,764,093.45 |
| Taxes Payable |
58,284,195.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,748,806.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,375,374.25 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
581,982,657.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,476,606.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,310,158.84 |
| Total Liabilities |
684,292,816.27 |
| Paid-In Capital(Or Share Stock) |
331,853,600.00 |
| Capital Surplus |
1,433,036,691.33 |
| Surplus Reserve |
158,193,809.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,148,993,125.92 |
| Minority Stockholder's Interest |
630,244,340.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,096,541,874.32 |
| Owner's Equity（Stockholder's Equity） |
3,726,786,215.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,411,079,031.35 |
